Exact Mass: 535.1737

Exact Mass Matches: 535.1737

Found 18 metabolites which its exact mass value is equals to given mass value 535.1737, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Phosphoribosylparomamine

C17H34N3O14P (535.1778)

Davallioside A

[ (2R) -5,7-Dihydroxy-2alpha- (3,4-dihydroxyphenyl) -8- (2-pyrrolizinon-5-yl) chroman-3alpha-yl ] beta-D-allopyranoside

C25H29NO12 (535.169)

Davallioside B

C25H29NO12 (535.169)

Piperacillin

Piperacillin hydrate

C23H29N5O8S (535.1737)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

4-Isothiocyanatorhodamine B

C29H30ClN3O3S (535.1696)

N,N-Dimethyl-3-[4-[(E)-[2-(4-methylpiperidin-1-yl)-4-oxo-1,3-thiazol-5-ylidene]methyl]-1-phenylpyrazol-3-yl]benzenesulfonamide

C27H29N5O3S2 (535.1712)

PF-06424439 (methanesulfonate)

C23H30ClN7O4S (535.1768)

PF-06424439 methanesulfonate is an oral, potent and selective imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitor with an IC50 of 14 nM[1]. PF-06424439 methanesulfonate is slowly reversible, time-dependent inhibitor, which inhibits DGAT2 in a noncompetitive mode with respect to the acyl-CoA substrate[2].

(2r,5s,6r)-2-{[(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C25H29NO12 (535.169)

(2r,3r,4r,5s,6r)-2-{[(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C25H29NO12 (535.169)

2-{[2-({[2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxy-2-(pyrrolidin-2-yl)ethylidene]amino}-3-hydroxy-2-methylpropanoic acid

C24H30ClN5O7 (535.1834)

2-{[(2s)-2-({[(4s)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxy-2-[(2r)-pyrrolidin-2-yl]ethylidene]amino}-3-hydroxy-2-methylpropanoic acid

2-{[(2s)-2-({[(4s)-2-(6-chloro-4-hydroxy-1-methylindol-3-yl)-4-methyl-5h-1,3-oxazol-4-yl](hydroxy)methylidene}amino)-1-hydroxy-2-[(2r)-pyrrolidin-2-yl]ethylidene]amino}-3-hydroxy-2-methylpropanoic acid

C24H30ClN5O7 (535.1834)

2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C25H29NO12 (535.169)

(2r,3r,4s,5r,6r)-2-{[(2r,3s)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C25H29NO12 (535.169)